Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis

Saved in:
Bibliographic Details
Published in:Obesity Science & Practice
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553968262578177
collection WordPress RSS
FRELIP Feed Integration
container_title Obesity Science & Practice
description
discipline_display Physical Fitness and Hygiene
discipline_facet Physical Fitness and Hygiene
format Online Article
RSS Article
genre Journal Article
id rss_article:92127
institution FRELIP
journal_source_facet Obesity Science & Practice
last_indexed 2026-06-20T21:45:12.453Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis
Physical Fitness and Hygiene
General
Physical Fitness and Hygiene
sub_discipline_display General
sub_discipline_facet General
subject_display Physical Fitness and Hygiene
General
Physical Fitness and Hygiene
subject_facet Physical Fitness and Hygiene
General
Physical Fitness and Hygiene
title Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis
title_alt Identificación de predictores de resultados relacionados con el peso con naltrexona y bupropión de liberación prolongada en dosis fija entre pacientes adherentes al tratamiento en los ensayos COR de fase 3: un análisis de objetivos de tratamiento
Identification des prédicteurs des résultats pondéraux avec la naltrexone et le bupropion à libération prolongée à dose fixe chez les patients adhérents au traitement dans les essais COR de phase 3 : une analyse des cibles thérapeutiques
Identificação de Preditores de Resultados Relacionados ao Peso com Naltrexona e Bupropiona de Liberação Prolongada em Dose Fixa entre Pacientes Adesivos ao Tratamento nos Ensaios Clínicos COR de Fase 3: Uma Análise de Alvo de Tratamento
title_auth Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis
title_es_txt Identificación de predictores de resultados relacionados con el peso con naltrexona y bupropión de liberación prolongada en dosis fija entre pacientes adherentes al tratamiento en los ensayos COR de fase 3: un análisis de objetivos de tratamiento
title_fr_txt Identification des prédicteurs des résultats pondéraux avec la naltrexone et le bupropion à libération prolongée à dose fixe chez les patients adhérents au traitement dans les essais COR de phase 3 : une analyse des cibles thérapeutiques
title_full Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis
title_fullStr Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis
title_full_unstemmed Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis
title_pt_txt Identificação de Preditores de Resultados Relacionados ao Peso com Naltrexona e Bupropiona de Liberação Prolongada em Dose Fixa entre Pacientes Adesivos ao Tratamento nos Ensaios Clínicos COR de Fase 3: Uma Análise de Alvo de Tratamento
title_short Identifying Predictors of Weight‐Related Outcomes With Fixed‐Dose, Extended‐Release Naltrexone and Bupropion Among Treatment‐Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis
title_sort identifying predictors of weight‐related outcomes with fixed‐dose, extended‐release naltrexone and bupropion among treatment‐adherent patients in phase 3 cor trials: a treatment target analysis
topic Physical Fitness and Hygiene
General
Physical Fitness and Hygiene
url https://onlinelibrary.wiley.com/doi/10.1002/osp4.70159?af=R